Login to Your Account

Clinic Roundup

Tuesday, June 19, 2012
• Cell Therapeutics Inc., of Seattle, said the University of Washington has begun enrolling patients in a randomized Phase II trial testing tosedostat with either cytarabine or decitabine for elderly patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription